These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16685591)

  • 1. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
    Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
    Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nipple aspirate fluid color is associated with breast cancer.
    Sauter ER; Winn JN; Dale PS; Wagner-Mann C
    Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study.
    Kato I; Ren J; Visscher DW; Djuric Z
    Breast Cancer Res Treat; 2006 May; 97(1):33-9. PubMed ID: 16317581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
    Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.
    Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF
    Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
    Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.
    Mitchell G; Antill YC; Murray W; Kirk J; Salisbury E; Lindeman GJ; Di Iulio J; Milner AD; Devereaux L; Phillips KA
    Breast Cancer Res; 2005; 7(6):R1122-31. PubMed ID: 16457692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
    Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
    Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
    Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
    Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
    Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer.
    Sauter ER; Klein G; Wagner-Mann C; Diamandis EP
    Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
    Kumar SR; Sauter ER; Quinn TP; Deutscher SL
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens.
    Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ
    Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs.
    Sauter ER; Ganz PA; Ehya H; Hewett JE; Schlatter L; Kliethermes B; Daly MB
    Breast; 2007 Oct; 16(5):489-94. PubMed ID: 17482465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen production in the female breast: association with progesterone.
    Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.